ConductScience.org, home

Trial · NCT02804399

Results by group112

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Plasma AUCinf for PF-06463922 Given Alone and With RifampinPF-06463922 100 mg8766Geometric Coefficient of Variation 19nanogram (ng)*hr/ millilitre (mL)
Plasma AUCinf for PF-06463922 Given Alone and With RifampinRifampin 600 mg + PF-06463922 100 mg1299Geometric Coefficient of Variation 30nanogram (ng)*hr/ millilitre (mL)
Plasma Cmax for PF-06463922 Given Alone and With RifampinPF-06463922 100 mg621.4Geometric Coefficient of Variation 26ng/mL
Plasma Cmax for PF-06463922 Given Alone and With RifampinRifampin 600 mg + PF-06463922 100 mg148.4Geometric Coefficient of Variation 31ng/mL
Plasma AUClast for PF-06463922 Given Alone and With RifampinPF-06463922 100 mg8597Geometric Coefficient of Variation 19ng•hr/mL
Plasma AUClast for PF-06463922 Given Alone and With RifampinRifampin 600 mg + PF-06463922 100 mg1200Geometric Coefficient of Variation 32ng•hr/mL
Plasma Tmax for PF-06463922 Given Alone and With RifampinPF-06463922 100 mg1.50Full Range 0.683 to 2.00hr
Plasma Tmax for PF-06463922 Given Alone and With RifampinRifampin 600 mg + PF-06463922 100 mg1.51Full Range 1.00 to 4.00hr
Plasma t1/2 for PF-06463922 Given Alone and With RifampinPF-06463922 100 mg21.22Standard Deviation 4.12hr
Plasma t1/2 for PF-06463922 Given Alone and With RifampinRifampin 600 mg + PF-06463922 100 mg10.16Standard Deviation 2.43hr
Plasma CL/F for PF-06463922 Given Alone and With RifampinPF-06463922 100 mg11.39Geometric Coefficient of Variation 20L/hr
Plasma CL/F for PF-06463922 Given Alone and With RifampinRifampin 600 mg + PF-06463922 100 mg76.91Geometric Coefficient of Variation 30L/hr
Plasma Vz/F for PF-06463922 Given Alone and With RifampinPF-06463922 100 mg342.6Geometric Coefficient of Variation 19liter
Plasma Vz/F for PF-06463922 Given Alone and With RifampinRifampin 600 mg + PF-06463922 100 mg1095Geometric Coefficient of Variation 47liter
Plasma AUClast for PF-06895751 When PF-06463922 Given Alone and With RifampinPF-06463922 100 mg4105Geometric Coefficient of Variation 33ng*hr/mL
Plasma AUClast for PF-06895751 When PF-06463922 Given Alone and With RifampinRifampin 600 mg + PF-06463922 100 mg3169Geometric Coefficient of Variation 60ng*hr/mL
Plasma AUCinf for PF-06895751 When PF-06463922 Given Alone and With RifampinPF-06463922 100 mg4453Geometric Coefficient of Variation 38ng•hr/mL
Plasma AUCinf for PF-06895751 When PF-06463922 Given Alone and With RifampinRifampin 600 mg + PF-06463922 100 mg3291Geometric Coefficient of Variation 60ng•hr/mL
Plasma Tmax for PF-06895751 When PF-06463922 Given Alone and With Rifampin.PF-06463922 100 mg30.1Full Range 24.0 to 36.1hr
Plasma Tmax for PF-06895751 When PF-06463922 Given Alone and With Rifampin.Rifampin 600 mg + PF-06463922 100 mg12.0Full Range 6.00 to 36.1hr

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02804399/results